AbbVie
ProfileJobs (747)

AbbVie

Suggest Edit
    • Healthcaredrug developmenthealthtechpharma
    AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs. The Company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the treatment of patients with chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for the treatment of adults with genotype 1 chronic hepatitis C.
    Revenue(FY, 2016)
    $25.6 B
    Market capitalization(2018-11-09)
    $133.6 B

    Employee Rating

    3.7More
    TypePublic
    HQNorth Chicago, US
    Founded2013
    Size (employees)30,000 (est)+4%
    Websiteabbvie.com
    AbbVie was founded in 2013 and is headquartered in North Chicago, US
    Report incorrect company information

    Viewing summary data as a guest

    Sign up for free to see all data

    Key People/Management at AbbVie

    Richard Gonzalez

    Richard Gonzalez

    Chairman of the Board and Chief Executive Officer
    Carlos Alban

    Carlos Alban

    Executive Vice President, Commercial Operations
    Timothy Richmond

    Timothy Richmond

    Senior Vice President, Human Resources​
    Azita Saleki-Gerhardt

    Azita Saleki-Gerhardt

    Senior Vice President, Operations
    Karen Hale

    Karen Hale

    Vice President, Chief Ethics and Compliance Officer
    Wulff-Erik von Borcke

    Wulff-Erik von Borcke

    President, Pharmacyclics
    Show more

    AbbVie Office Locations

    AbbVie has offices in Singapore, Campoverde, Sligo, San Francisco and in 12 other locations
    North Chicago, US (HQ)
    1 Waukegan Rd
    Cambridge, US
    200 Sidney St
    Barceloneta, PR
    PR-2
    Show all (16)
    Report incorrect company information

    AbbVie Financials and Metrics

    AbbVie Revenue

    Embed Graph
    AbbVie's revenue was reported to be $25.64 b in FY, 2016 which is a 12.2% increase from the previous period.
    USD

    Revenue (Q3, 2018)

    		8.2b

    Gross profit (Q3, 2018)

    		6.4b

    Gross profit margin (Q3, 2018), %

    		77.7%

    Net income (Q3, 2018)

    		2.7b

    EBIT (Q3, 2018)

    		3.2b

    Market capitalization (9-Nov-2018)

    		133.6b

    Closing stock price (9-Nov-2018)

    		88.8

    Cash (30-Sep-2018)

    		8.0b

    EV

    		128.5b
    AbbVie's current market capitalization is $133.6 b.
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Revenue

    		18.8b20.0b22.9b25.6b

    Revenue growth, %

    		6%15%12%

    Cost of goods sold

    		4.6b4.4b4.5b5.8b

    Gross profit

    		14.2b15.5b18.4b19.8b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

    Revenue

    		4.7b4.6b4.9b5.0b5.0b5.5b5.9b6.0b6.5b6.4b6.5b6.9b7.0b7.9b8.3b8.2b

    Cost of goods sold

    		1.1b1.1b1.1b1.1b942.0m916.0m1.2b1.4b1.4b1.5b1.6b1.5b1.6b1.9b1.9b1.8b

    Gross profit

    		3.6b3.5b3.8b3.9b4.1b4.6b4.8b4.6b5.0b4.9b4.9b5.4b5.4b6.0b6.3b6.4b

    Gross profit Margin, %

    		77%76%77%78%81%83%80%77%78%77%75%78%77%76%77%78%
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Cash

    		9.6b8.3b8.4b5.1b

    Accounts Receivable

    		3.9b3.7b4.7b4.8b

    Inventories

    		1.2b1.1b1.7b1.4b

    Current Assets

    		17.8b16.1b16.3b16.2b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

    Cash

    		9.0b8.1b9.1b7.7b7.9b7.4b9.2b7.6b6.3b6.2b4.7b6.1b8.4b9.0b3.5b8.0b

    Accounts Receivable

    		3.8b3.7b3.7b3.6b4.2b4.4b4.6b4.8b5.0b5.0b4.7b4.9b4.9b5.8b5.8b5.8b

    Inventories

    		1.2b1.1b1.0b1.0b1.0b1.6b1.8b1.8b1.8b1.6b1.4b1.6b1.8b1.7b1.6b1.8b

    Current Assets

    		16.5b17.3b17.8b17.6b15.4b16.9b17.9b16.6b16.8b16.3b15.5b17.0b18.9b20.4b13.8b18.5b
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Net Income

    		4.1b1.8b5.1b6.0b

    Inventories

    		(56.0m)(203.0m)(434.0m)(38.0m)

    Accounts Payable

    		(426.0m)(193.0m)1.5b(1.2b)

    Cash From Operating Activities

    		6.3b3.5b7.5b7.0b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

    Net Income

    		3.0b980.0m2.1b2.6b1.0b2.4b3.6b1.4b3.0b4.6b1.7b3.6b5.3b2.8b4.8b7.5b

    Depreciation and Amortization

    		697.0m199.0m401.0m593.0m158.0m348.0m575.0m268.0m557.0m861.0m374.0m753.0m1.1b445.0m888.0m1.3b

    Inventories

    		(86.0m)50.0m97.0m20.0m(75.0m)(160.0m)(446.0m)19.0m(160.0m)28.0m71.0m1.0m(119.0m)(71.0m)(191.0m)(367.0m)

    Accounts Payable

    		227.0m(612.0m)(217.0m)(1.0m)188.0m409.0m1.3b42.0m89.0m(975.0m)(266.0m)(530.0m)444.0m191.0m12.0m881.0m
    show all
    USDY, 2018

    EV/EBIT

    		40.7 x

    Debt/Equity

    		-1 x

    Financial Leverage

    		-22.7 x
    Show all financial metrics

    AbbVie Acquisitions / Subsidiaries

    Acquired CompanyDateDeal Size
    Stem CentRxApril 28, 2016$5.80 b
    Report incorrect company information

    Competitors

    Johnson & Johnson
    Healthcare - Public
    Roche
    Healthcare - Public
    Novartis
    Healthcare - Public
    GlaxoSmithKline
    Healthcare - Public
    MyoKardia
    Healthcare - Public
    Compare competitors

    AbbVie Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    AbbVie News and Updates

    November 07, 2018

    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline - ABBV

    NEW YORK, Nov. 7, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against AbbVie Inc. ("AbbVie" or the "Company") (NYSE: ABBV) and certain of its officers. The class action, filed in United States District Court, Northern District of Illinois, and...
    November 06, 2018

    AbbVie Announces HUMIRA® (adalimumab) Global Patent License with Momenta

    NORTH CHICAGO, Ill., Nov. 6, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today patent license agreements with Momenta over its proposed biosimilar adalimumab product. Under the terms of the agreements, AbbVie will grant Momenta a non-exclusive license on specified dates to AbbVie's ...
    November 06, 2018

    Momenta Pharmaceuticals Announces Global Settlement with AbbVie to Enable Commercialization of M923, a Proposed Biosimilar to HUMIRA® (adalimumab)

    CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) today announced that it has executed agreements with AbbVie Inc., providing license rights for the global launch of M923, Momenta’s proposed biosimilar to HUMIRA. Under the terms of the agreements and …
    November 02, 2018

    AbbVie Best-Seller Humira Shows Its Mortality

    AbbVie Best-Seller Humira Shows Its Mortality
    November 02, 2018

    AbbVie sees hit to Humira sales from European competition

    U.S. drugmaker AbbVie Inc on Friday lowered its overseas sales forecast for its top-selling medicine, Humira, as it agreed to larger-than-expected price cuts due to new European competition.
    November 02, 2018

    Humira biosimilars available at up to 80 percent discount in Europe: AbbVie

    AbbVie Inc said on Friday rival biosimilar versions of its best-selling drug Humira were available in Europe at discounts ranging from 10 percent to 80 percent.
    Show more
    Report incorrect company information

    AbbVie Company Life and Culture

    Report incorrect company information
    Download PDF

     AbbVie Frequently Asked Questions

    wdxefcqufszuzezftuxetqsqxt

    • When was AbbVie founded?

      AbbVie was founded in 2013.

    • Who are AbbVie key executives?

      AbbVie's key executives are Richard Gonzalez, Carlos Alban and Timothy Richmond.

    • How many employees does AbbVie have?

      AbbVie has 30,000 employees.

    • What is AbbVie revenue?

      Latest AbbVie annual revenue is $25.6 b.

    • What is AbbVie revenue per employee?

      Latest AbbVie revenue per employee is $854.6 k.

    • Who are AbbVie competitors?

      Competitors of AbbVie include Johnson & Johnson, Roche and Novartis.

    • Where is AbbVie headquarters?

      AbbVie headquarters is located at 1 Waukegan Rd, North Chicago.

    • Where are AbbVie offices?

      AbbVie has offices in Singapore, Campoverde, Sligo, San Francisco and in 12 other locations.

    • How many offices does AbbVie have?

      AbbVie has 16 offices.